Cancer Biomarkers

Nanjing, China, September 1, 2026 Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group, has entered into an exclusive global...

Dallas, Texas, September 1, 2026 Cizzle Bio, Inc. has announced the publication of a new peer-reviewed study providing additional...

Irving, Texas, United States, Aug 27, 2026 Caris Life Sciences has announced the publication of a study in npj...

RAHWAY, N.J., June 11, 2026 Merck Animal Health, a division of Merck & Co., Inc., has signed a definitive...

TUCSON, Arizona, USA, June 11, 2026 Roche Diagnostics has announced a significant expansion of its precision oncology diagnostics portfolio...

HEIDELBERG, Germany, June 2, 2026 Hummingbird Diagnostics announced new research findings that provide important biological evidence supporting its liquid...

LUND, Sweden, May 27, 2026 Hansa Biopharma AB has announced positive topline results from its European Post Authorization Efficacy...

BOSTON, May 27, 2026 TransCode Therapeutics, Inc., a clinical-stage biotechnology company focused on RNA-based cancer therapeutics, has announced the...

NASHIK, India, May 21, 2026 Datar Cancer Genetics (DCG) has achieved a major milestone in precision oncology after receiving...

IRVING, Texas, May 8, 2026 Caris Life Sciences® has submitted an application to the New York State Department of...